Induction of bystander tolerance and immune deviation following Fel d 1 Peptide Immunotherapy.

These observations suggest that immune tolerance induced by peptide immunotherapy can be used experimentally to treat an allergic response to another allergen, and that the molecular mechanisms underlying the induction of tolerance to a treatment-specific allergen and a bystander allergen may be different.